Zu-yun Li

928 total citations
27 papers, 756 citations indexed

About

Zu-yun Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zu-yun Li has authored 27 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 18 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Zu-yun Li's work include Cancer-related molecular mechanisms research (16 papers), MicroRNA in disease regulation (12 papers) and RNA modifications and cancer (12 papers). Zu-yun Li is often cited by papers focused on Cancer-related molecular mechanisms research (16 papers), MicroRNA in disease regulation (12 papers) and RNA modifications and cancer (12 papers). Zu-yun Li collaborates with scholars based in China. Zu-yun Li's co-authors include Gang Chen, Dianzhong Luo, Yi‐Wu Dang, Ruixue Tang, Kang‐Lai Wei, Xin Zhang, Ting‐Qing Gan, Rong‐Quan He, Fanghui Ren and Xiaohua Hu and has published in prestigious journals such as PLoS ONE, Oncotarget and Biomedicine & Pharmacotherapy.

In The Last Decade

Zu-yun Li

27 papers receiving 750 citations

Peers

Zu-yun Li
Fang Zhu China
Gloria Manzotti Italy
Jia‐Quan Qu China
Stephanie Cabarcas‐Petroski United States
Helen Sadik United States
Juanni Li China
Junwei Song China
Skjalg Bruheim Norway
Jianian Zhang China
Fang Zhu China
Zu-yun Li
Citations per year, relative to Zu-yun Li Zu-yun Li (= 1×) peers Fang Zhu

Countries citing papers authored by Zu-yun Li

Since Specialization
Citations

This map shows the geographic impact of Zu-yun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zu-yun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zu-yun Li more than expected).

Fields of papers citing papers by Zu-yun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zu-yun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zu-yun Li. The network helps show where Zu-yun Li may publish in the future.

Co-authorship network of co-authors of Zu-yun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zu-yun Li. A scholar is included among the top collaborators of Zu-yun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zu-yun Li. Zu-yun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zu-yun, Ting‐Qing Gan, Ye‐Ying Fang, et al.. (2020). Downregulation of hsa-microRNA-204-5p and identification of its potential regulatory network in non-small cell lung cancer: RT-qPCR, bioinformatic- and meta-analyses. Respiratory Research. 21(1). 60–60. 12 indexed citations
2.
Chen, Shangwei, Huiping Lu, Gang Chen, et al.. (2020). Downregulation of miRNA‐126‐3p is associated with progression of and poor prognosis for lung squamous cell carcinoma. FEBS Open Bio. 10(8). 1624–1641. 11 indexed citations
3.
Gao, Li, Yi‐Wu Dang, Ping Li, et al.. (2019). Protective potential of miR-146a-5p and its underlying molecular mechanism in diverse cancers: a comprehensive meta-analysis and bioinformatics analysis. Cancer Cell International. 19(1). 167–167. 14 indexed citations
4.
5.
Gao, Li, Rong‐Quan He, Huayu Wu, et al.. (2018). Expression Signature and Role of miR-30d-5p in Non-Small Cell Lung Cancer: a Comprehensive Study Based on in Silico Analysis of Public Databases and in Vitro Experiments. Cellular Physiology and Biochemistry. 50(5). 1964–1987. 20 indexed citations
6.
Xiong, Dandan, Zu-yun Li, Lu Liang, et al.. (2018). The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA. Cellular Physiology and Biochemistry. 48(3). 905–918. 68 indexed citations
7.
8.
He, Rong‐Quan, Li Gao, Jie Ma, et al.. (2018). Oncogenic role of miR‑183‑5p in lung adenocarcinoma: A comprehensive study of qPCR, in�vitro experiments and bioinformatic analysis. Oncology Reports. 40(1). 83–100. 18 indexed citations
9.
Chen, Wenjie, Ting‐Qing Gan, Hui Qin, et al.. (2017). Implication of downregulation and prospective pathway signaling of microRNA-375 in lung squamous cell carcinoma. Pathology - Research and Practice. 213(4). 364–372. 26 indexed citations
10.
11.
Xiong, Dandan, Zhen‐Bo Feng, Jingjing Zeng, et al.. (2017). The clinical value of lncRNA NEAT1 in digestive system malignancies: A comprehensive investigation based on 57 microarray and RNA-seq datasets. Oncotarget. 8(11). 17665–17683. 27 indexed citations
12.
13.
14.
Chen, Gang, Yu Zhang, Jie Luo, et al.. (2016). Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases. OncoTargets and Therapy. Volume 9. 4959–4968. 16 indexed citations
15.
Ren, Fanghui, Ruixue Tang, Xin Zhang, et al.. (2015). Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis. PLoS ONE. 10(8). e0135544–e0135544. 160 indexed citations
16.
Wei, Kang‐Lai, Zhihua Ye, Zu-yun Li, et al.. (2015). An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker. World Journal of Surgical Oncology. 14(1). 34–34. 26 indexed citations
17.
Li, Zu-yun, et al.. (2015). Expression and clinical contribution of MRGD mRNA in non-small cell lung cancers.. PubMed. 20(4). 1101–6. 4 indexed citations
18.
Chen, Wenjie, Su-Ning Huang, Yiwu Dang, et al.. (2015). Insights into the clinical value of cyclin-dependent kinase 5 in glioma: a retrospective study. World Journal of Surgical Oncology. 13(1). 223–223. 25 indexed citations
19.
Li, Zu-yun, et al.. (2014). Therapeutic effects of intrathecal versus intravenous monosialoganglioside against bupivacaine-induced spinal neurotoxicity in rats. Biomedicine & Pharmacotherapy. 69. 311–316. 17 indexed citations
20.
Li, Zu-yun, et al.. (2005). [Clinicopathological and immunohistochemical study of extra-gastrointestinal stromal tumors arising from the omentum and mesentery].. PubMed. 34(1). 11–4. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fang Zhu Breakdown of academic impact, for papers by Gloria Manzotti Breakdown of academic impact, for papers by Jia‐Quan Qu Breakdown of academic impact, for papers by Stephanie Cabarcas‐Petroski Breakdown of academic impact, for papers by Helen Sadik Breakdown of academic impact, for papers by Juanni Li Breakdown of academic impact, for papers by Junwei Song Breakdown of academic impact, for papers by Skjalg Bruheim Breakdown of academic impact, for papers by Jianian Zhang
Rankless by CCL
2026